OBJECTIVE:
To determine whether meconium-stained amniotic fluid (MSAF) encountered in pregnancies complicated by preterm premature rupture of membranes (PPROM) is associated with adverse perinatal outcome. STUDY DESIGN: A retrospective cohort study reviewing delivery files of all pregnancies with PPROM and MSAF during labor who delivered in a tertiary hospital at 24 to 36(+6) weeks of gestation between 2007 and 2017. The study group consisted of 87 PPROM-MSAF deliveries (cases) that were matched to 261 deliveries with clear amniotic fluid PPROM based on age, number of fetuses, gravidity, parity and week of delivery (controls). The association of amniotic fluid type with pregnancy outcome was examined. Neonatal respiratory morbidity was defined as the presence of any of the following: respiratory distress syndrome, transient tachypnea of the newborn, meconium aspiration syndrome, or need for ventilatory support. RESULTS: Baseline characteristics were similar in cases and controls except for a lower prevalence of preeclampsia in the controls group (0.4% vs. 5.8%, p¼0.004) ( OBJECTIVE: Persuasive clinical trials data suggest that low-risk women identified as having a short cervical length (CL) on midtrimester ultrasound benefit from vaginal progesterone to reduce the risk of preterm birth (PTB). The successful introduction of universal CL screening programs using an "opt-out" approach has been reported. The aim of this study was to compare the risk of PTB among women who did and did not agree to participate in an "opt-in" CL screening program STUDY DESIGN: This was a retrospective cohort study of women carrying a singleton gestation who had an anatomy ultrasound performed between 16w0d-23w6d, and delivered at a single medical center from 7/2014-3/2017. CL screening was offered at time of anatomy ultrasound. Women with CL 20 mm were offered vaginal progesterone; follow-up evaluation in 1-2 weeks was recommended with CL between 21-25 mm. A history of spontaneous PTB and major fetal anomalies were exclusion criteria. Demographic characteristics were compared between screened and unscreened women. Rates of CL 20mm and CL 21-25mm, and progesterone use in the screened group were assessed. Rates of PTB <37 weeks were compared in the two groups. The rates of PTB <34 and <28 weeks gestation, and spontaneous PTB, were also analyzed. Multivariable logistic regression was used to adjust for confounding. RESULTS: Of the 6,170 women included in the study, 2,410 (39.1%) opted-in for CL screening. Screened women were more likely to be nulliparous, to have conceived with fertility treatment, and to have a prior cervical excisional procedure. Unscreened women were more likely to have public insurance. Overall incidence of CL 20 mm among screened women was 1.7% (40/2,410), and 38 of these women started progesterone. 33 women (1.4%) had a CL 20 mm on initial scan. 40 women (1.7%) had CL 21-25 mm; 31 of these women had a follow-up CL of whom 7 (22.6%) had a CL 20 mm. Rates of PTB and spontaneous PTB <37, <34, and <28 did not differ among screened and unscreened women after adjusting for parity, black race, insurance type, tobacco use, and history of cervical excisional procedure (Table) . CONCLUSION: No difference in PTB rates were seen among women undergoing universal CL screening using an "opt-in" approach. This contrasts with prior studies reporting decreased PTB rates in women screened using an "opt-out" approach. Further research comparing these two approaches to CL screening is recommended. OBJECTIVE: Preterm prelabor rupture of membranes (PPROM) is an integral part of preterm birth. When PPROM occurs prior to the onset of clinically recognizable uterine contractions, and fetus is stable, the patient is often admitted for observation. Yet, bacterial activity and progression of the inflammatory process continue silently. Birth occurs when microbial invasion of gestational sac, fetal membranes, placenta and myometrium reach a critical point. We sought to investigate if delivery of the placenta and powerful contraction of the uterus is associated with an outpouring of bacterial DNA and cytokines in the maternal circulation of women with PPROM. STUDY DESIGN: 66 women (GA: 32AE1 wks) had a confirmed diagnosis of PPROM. All women received antibiotics and steroids and were followed prospectively until delivery consistent with ACOG guidelines for management of PPROM. Maternal blood was retrieved via sterile venous puncture during the quiescent period and within 1 h post-partum (PP). At birth placental and fetal membrane tissues were collected and frozen in sterile fashion. A specific primerprobe was used for maternal blood and tissues bacterial quantification based on amplification of 16s rDNA by RT-PCR (data normalized to housekeeping gene GPI). Cord blood was collected and analyzed for haptoglobin (Hp) as a biomarker of antenatal exposure to inflammation. Maternal blood was analyzed for a panel of 10 cytokines by multiplex fluorescent immunoassay. RESULTS: Albeit at low level, bacterial DNA was consistently identified in maternal blood both before and after birth. A significant decrease in maternal blood bacterial DNA was observed 1 h PP (dCt, before: 1.3x10 -3 vs PP 0.9x10 -3 fold change, P¼.004). Conversely, levels of pro-(IL-6, IL-8, TNFa) and anti-(IL-10) inflammatory cytokines significantly increased (P<.05 for all) 1 h PP. In
